0001157523-21-000953.txt : 20210730 0001157523-21-000953.hdr.sgml : 20210730 20210729180300 ACCESSION NUMBER: 0001157523-21-000953 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20210729 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210730 DATE AS OF CHANGE: 20210729 FILER: COMPANY DATA: COMPANY CONFORMED NAME: APTARGROUP INC CENTRAL INDEX KEY: 0000896622 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS PRODUCTS, NEC [3089] IRS NUMBER: 363853103 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11846 FILM NUMBER: 211129031 BUSINESS ADDRESS: STREET 1: 475 W TERRA COTTA AVE STREET 2: STE E CITY: CRYSTAL LAKE STATE: IL ZIP: 60014 BUSINESS PHONE: 8154770424 MAIL ADDRESS: STREET 1: 475 W. TERRA COTTA AVE. SUITE E CITY: CRYSTAL LAKE STATE: IL ZIP: 60014 8-K 1 a52468729.htm APTARGROUP INC 8-K
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


July 29, 2021
Date of Report (Date of earliest event reported)

AptarGroup, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
001-11846
36-3853103
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
     
265 Exchange Drive, Suite 100, Crystal Lake, Illinois 60014
(Address of principal executive offices)
 
Registrant’s telephone number, including area code: 815-477-0424.
 
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock, $.01 par value
 
ATR
 
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company    ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Item 2.02          Results of Operations and Financial Condition.
 
On July 29, 2021, AptarGroup, Inc. announced certain information related to its results of operations for the quarter and six months ended June 30, 2021. The press release regarding this announcement is furnished as Exhibit 99.1 hereto.

The information in Item 2.02 of this Form 8-K and the Exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
 
Item 9.01          Financial Statements and Exhibits.
 
(d) Exhibits
 
 
104            Cover Page Interactive Data File (embedded within the Inline XBRL document).
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
   
AptarGroup, Inc.
  
       
       
Date:  July 29, 2021
By:
/s/Robert W. Kuhn
  
   
Robert W. Kuhn
Executive Vice President and Chief Financial Officer


2
 EX-99.1 2 a52468729ex99_1.htm EXHIBIT 99.1
Exhibit 99.1

Aptar Reports Second Quarter 2021 Results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--July 29, 2021--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today reported second quarter results for 2021.

Second Quarter 2021 Summary

  • Reported sales grew 16% driven by strong core sales growth and positive currency effects
  • Core sales (excluding currency effects) increased 10% mainly on double digit core growth in Beauty + Home and Food + Beverage, driven by increased demand for our innovative dispensing solutions along with price adjustments related to rising input costs
  • Reported earnings per share totaled $0.81 (an increase of 29% compared to the prior year)
  • Adjusted earnings per share, excluding restructuring charges, acquisition costs and the loss on an equity investment, totaled $0.91 (an increase of 7% compared to the prior year when neutralizing currency effects)
  • Reported net income totaled $55 million for the second quarter (an increase of 32% compared to the prior year) and $139 million year-to-date (an increase of 43% compared to the prior year)
  • Adjusted EBITDA totaled $148 million for the second quarter (an increase of 8% compared to the prior year) and $300 million year-to-date (an increase of 7% compared to the prior year)
  • Cash flow from operations was $176 million in the first half of 2021 (a decrease of 23% compared to the prior year)
  • Free cash flow was $39 million in the first half of 2021 (a decrease of 63% compared to the prior year) primarily due to increased investments for growth (capital expenditures and working capital)
  • Subsequent to the end of the quarter, the Company announced:
    • A share purchase agreement regarding the acquisition of a majority stake in Voluntis, a pioneer in digital therapeutics
    • A strategic collaboration with YAT, a Chinese online skincare company, to develop a range of products and services for the skincare market
    • An agreement to acquire 80% of Weihai Hengyu Medical Products, adding elastomeric and plastic component manufacturing capabilities in China for injectable drug delivery

Second Quarter Results

For the quarter ended June 30, 2021, reported sales increased 16% to $811 million compared to $699 million in the prior year. Core sales, excluding the impact from changes in currency exchange rates, increased 10%.

Second Quarter Segment Sales Analysis
(Change Over Prior Year)


Pharma

Beauty + Home

Food + Beverage

Total AptarGroup

Core Sales Growth

2%

13%

23%

10%

Acquisitions

0%

0%

0%

0%

Currency Effects (1)

6%

7%

5%

6%

Total Reported Sales Growth

8%

20%

28%

16%

(1) - Currency effects are approximated by translating last year's amounts at this year's foreign exchange rates.

Commenting on the quarter, Stephan B. Tanda, President and CEO, said, “The wide breadth of our innovative solutions and services, serving thousands of customers across multiple markets, continues to be a strength of Aptar. We achieved core sales growth in each segment and consolidated double-digit core sales growth despite the ongoing reduction of allergic rhinitis and cough and cold product inventory levels by customers served by our prescription drug and consumer healthcare units. We will continue to take action to mitigate the effects of a rising input cost environment, which compressed our margins during the quarter, particularly in Beauty + Home and Food + Beverage. Despite the issues we faced in the quarter, we expect a recovery in the second half, especially as we get toward the end of the year.”

Aptar’s Beauty + Home segment generated strong core sales growth over the prior year second quarter, which was the height of the pandemic. Approximately 75% of the growth came from increased volumes. Increased sales to the beauty market were driven by demand for fragrance and facial skincare solutions. In the personal care market, increased sales to the hair care and sun care market were offset by declines in personal cleansing, as hand sanitizer demand began to normalize. The home care market experienced another solid quarter with strong demand for Aptar’s valves and pumps for a variety of applications. Price adjustments related to the initial passing through of higher resin and other input costs, and increased tooling sales, also contributed to the top line in the quarter.

Aptar’s Food + Beverage segment reported double-digit core sales growth with price adjustments related to higher resin costs accounting for approximately 60% of the sales increase. Volumes rose on increased demand for specialty food dispensing closures as consumers continued to cook at home, along with modest recovery in the beverage market compared to the prior year.

In the Pharma segment, increased demand for elastomeric components used with injected medicines and active material science solutions more than offset declines in the prescription drug and consumer health care markets. Similar to the first quarter, certain areas of the Pharma segment continue to be impacted by customers drawing down inventory levels as sectors such as allergic rhinitis and cough and cold have been impacted by low levels of patient consumption during the pandemic.

Aptar reported second quarter earnings per share of $0.81 compared to $0.63 during the same period a year ago, an increase of 29%. Second quarter adjusted earnings per share, excluding restructuring charges, acquisitions costs and the loss on an equity investment, were $0.91 and increased 7% from the prior year adjusted earnings per share, including comparable exchange rates, of $0.85.

Year-to-Date Results

For the six months ended June 30, 2021, reported sales increased 12% to $1.59 billion compared to $1.42 billion in the prior year. Core sales, excluding the impacts from changes in currency exchange rates and acquisitions, increased 5%.

Six Months Year-to-Date Segment Sales Analysis
(Change Over Prior Year)

Pharma

Beauty + Home

Food + Beverage

Total AptarGroup

Core Sales Growth

1%

5%

18%

5%

Acquisitions

0%

3%

0%

1%

Currency Effects (1)

6%

5%

4%

6%

Total Reported Sales Growth

7%

13%

22%

12%

(1) - Currency effects are approximated by translating last year's amounts at this year's foreign exchange rates.

Tanda commented on the year-to-date results, “I’m proud of the dedicated efforts of our people and the resiliency and agility we have shown in the first half of the year. We achieved core sales growth in each segment, and consolidated top line core sales growth of 5% with adjusted EBITDA growth of 7%. This is despite headwinds from the unprecedented inflationary environment even though we are implementing pricing adjustments to pass on these effects over time.”

For the six months year-to-date, Aptar’s reported earnings per share were $2.05, and increased 39%, compared to $1.47 reported a year ago. Current year adjusted earnings per share, excluding restructuring charges, acquisitions costs and the net gain on an equity investment, were $2.01 and increased 10% from prior year adjusted earnings per share, including comparable exchange rates, of $1.83. Free cash flow for the first six months was impacted by higher capital expenditures and changes in working capital, mainly increases in inventory and accounts receivable related to the recent sales growth and order activity.

Outlook

“For the third quarter, the broader macro factors impacting our business are not anticipated to change dramatically from what we experienced in the second quarter. Looking ahead, we believe the second half will initially show gradually improving operating results from our position today, and we expect accelerated improvement toward the end of the year,” said Tanda.

Third quarter results are anticipated to reflect continued gradual improvement in Aptar’s beauty and beverage businesses as the reopening of economies is expected to continue at a measured pace given the uncertainties around the COVID-19 variants and limited resumption of intercontinental travel. The current inventory destocking cycle by our customers in the prescription drug market is expected to continue through the third quarter, with improving performance toward the end of the year. Additionally, Aptar expects ongoing steady demand for elastomer components for injection devices in the third quarter. The exceptionally strong custom tooling sales reported in the prior year third quarter by the Pharma segment’s active material science solutions division, is not expected to repeat. While inflation and cost pressures continue to be a headwind, especially in raw material and transportation costs, Aptar will look to implement further price adjustments as necessary to pass on these costs over time.

“As we navigate through what has become a rather bumpy growth trajectory across our different markets, we continue to focus on returns across all areas of our business and anticipate that our consolidated margins will improve as we transition to a more balanced and steady growth pattern,” said Tanda. “Our long-term views have not changed. This is a tremendous company with outstanding talent and the fundamental growth story is intact across each of our markets. In addition, we are taking strategic actions such as our recently announced investments in complementary, high-quality businesses that will contribute to that story.”

Aptar expects earnings per share for the third quarter of 2021, excluding any restructuring expenses, acquisition costs and changes in the fair value of equity investments, to be in the range of $0.90 to $0.98 and this guidance is based on an effective tax rate range of 28% to 30%.

Cash Dividend

As previously announced, Aptar’s Board of Directors declared a quarterly cash dividend of $0.38 per share. The payment date is August 25, 2021, to stockholders of record as of August 4, 2021.

Open Conference Call

There will be a conference call on Friday, July 30, 2021 at 8:00 a.m. Central Time to discuss the Company’s second quarter results for 2021. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investor Relations page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investor Relations page of the website.

About Aptar

Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.

Presentation of Non-GAAP Information

This press release refers to certain non-GAAP financial measures, including current year adjusted earnings per share and adjusted EBITDA, which exclude the impact of business transformation charges (restructuring initiatives), acquisition-related costs, certain purchase accounting adjustments related to acquisitions and investments and net investment gains and losses related to observable market price changes on equity securities. Core sales and adjusted earnings per share also neutralize the impact of foreign currency translation effects when comparing current results to the prior year. Non-GAAP financial measures may not be comparable to similarly titled non-GAAP financial measures provided by other companies. Aptar’s management believes these non-GAAP financial measures provide useful information to our investors because they allow for a better period over period comparison of operating results by removing the impact of items that, in management’s view, do not reflect Aptar’s core operating performance. These non-GAAP financial measures also provide investors with certain information used by Aptar’s management when making financial and operational decisions. Free cash flow is calculated as cash provided by operating activities less capital expenditures. We use free cash flow to measure cash flow generated by operations that is available for dividends, share repurchases, acquisitions and debt repayment. We believe that it is meaningful to investors in evaluating our financial performance and measuring our ability to generate cash internally to fund our initiatives. These non-GAAP financial measures should not be considered in isolation or as a substitute for GAAP financial results but should be read in conjunction with the unaudited condensed consolidated statements of income and other information presented herein. A reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures is included in the accompanying tables. Our outlook is provided on a non-GAAP basis because certain reconciling items are dependent on future events that either cannot be controlled, such as exchange rates and changes in the fair value of equity investments, or reliably predicted because they are not part of the Company's routine activities, such as restructuring and acquisition costs.

This press release contains forward-looking statements, including certain statements set forth under the “Outlook” section of this press release. Words such as “expects,” “anticipates,” “believes,” “estimates,” “future,” “potential” and other similar expressions or future or conditional verbs such as “will,” “should,” “would” and “could” are intended to identify such forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on our beliefs as well as assumptions made by and information currently available to us. Accordingly, our actual results or other events may differ materially from those expressed or implied in such forward-looking statements due to known or unknown risks and uncertainties that exist in our operations and business environment including, but not limited to: pandemics, including the impact of the COVID-19 pandemic on our global supply chain and our global customers and operations; our ability to preserve organizational culture and maintain employee productivity in the work-from-home environment caused by the current pandemic; the successful integration of acquisitions and the achievement of the expected benefits of acquisitions and investments; the impact of tax reform legislation including changes in tax rates and other tax-related events or transactions that could impact our effective tax rate; the execution of the business transformation plan; economic conditions worldwide including potential deflationary or inflationary conditions or economic downturn or uncertainty in regions we rely on for growth as a result of the COVID-19 pandemic or otherwise; political conditions worldwide; significant fluctuations in foreign currency exchange rates; changes in customer and/or consumer spending levels; financial conditions of customers and suppliers; consolidations within our customer or supplier bases; the availability of direct labor workers and the increase in direct labor costs; fluctuations in the cost of materials, components and other input costs; the availability of raw materials and components; our ability to successfully implement facility expansions and new facility projects; our ability to increase prices, contain costs and improve productivity; changes in capital availability or cost, including interest rate fluctuations; volatility of global credit markets; cybersecurity threats that could impact our networks and reporting systems; fiscal and monetary policies and other regulations; direct or indirect consequences of acts of war or terrorism; and work stoppages due to labor disputes. For additional information on these and other risks and uncertainties, please see our filings with the Securities and Exchange Commission, including the discussion under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Form 10-K and Form 10-Qs. We undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

AptarGroup, Inc.
Condensed Consolidated Financial Statements (Unaudited)
(In Thousands, Except Per Share Data)
Consolidated Statements of Income





 

Three Months Ended

Six Months Ended



June 30,

June 30,



 

2021

 

 

2020

 

 

2021

 

 

2020

 







 
Net Sales

$

811,032

 

$

699,305

 

$

1,587,786

 

$

1,420,858

 


Cost of Sales (exclusive of depreciation and amortization shown below)

 

523,050

 

 

441,702

 

 

1,011,755

 

 

892,958

 


Selling, Research & Development and Administrative

 

140,913

 

 

123,365

 

 

275,261

 

 

249,557

 


Depreciation and Amortization

 

57,790

 

 

56,429

 

 

115,228

 

 

107,235

 


Restructuring Initiatives

 

4,876

 

 

7,331

 

 

8,548

 

 

12,170

 


Operating Income

 

84,403

 

 

70,478

 

 

176,994

 

 

158,938

 


Other Income (Expense):




Interest Expense

 

(7,175

)

 

(8,734

)

 

(14,590

)

 

(17,122

)


Interest Income

 

624

 

 

175

 

 

1,005

 

 

350

 


Net Investment (Loss) Gain

 

(1,611

)

 

-

 

 

15,198

 

 

-

 


Equity in Results of Affiliates

 

81

 

 

(328

)

 

(434

)

 

(1,127

)


Miscellaneous, net

 

(2,028

)

 

(923

)

 

(2,991

)

 

(2,335

)


Income before Income Taxes

 

74,294

 

 

60,668

 

 

175,182

 

 

138,704

 


Provision for Income Taxes

 

19,020

 

 

18,808

 

 

35,969

 

 

41,594

 


Net Income

$

55,274

 

$

41,860

 

$

139,213

 

$

97,110

 


Net Loss (Income) Attributable to Noncontrolling Interests

 

2

 

 

(21

)

 

15

 

 

(18

)


Net Income Attributable to AptarGroup, Inc.

$

55,276

 

$

41,839

 

$

139,228

 

$

97,092

 


Net Income Attributable to AptarGroup, Inc. per Common Share:




Basic

$

0.84

 

$

0.65

 

$

2.12

 

$

1.51

 


Diluted

$

0.81

 

$

0.63

 

$

2.05

 

$

1.47

 







 
Average Numbers of Shares Outstanding:




Basic

 

65,818

 

 

64,262

 

 

65,525

 

 

64,135

 


Diluted

 

68,086

 

 

66,384

 

 

67,869

 

 

66,246

 















 
AptarGroup, Inc.
Condensed Consolidated Financial Statements (Unaudited)
(continued)
($ In Thousands)
Consolidated Balance Sheets



 

June 30, 2021


December 31, 2020

ASSETS





 
Cash and Equivalents

$

291,495


$

300,137

Short-term Investments

 

-


 

243

Total Cash and Equivalents, and Short-term Investments

 

291,495


 

300,380

Accounts and Notes Receivable, Net

 

635,847


 

566,623

Inventories

 

429,440


 

379,379

Prepaid and Other Current Assets

 

135,672


 

122,613

Total Current Assets

 

1,492,454


 

1,368,995

Property, Plant and Equipment, Net

 

1,224,455


 

1,198,748

Goodwill

 

887,741


 

898,521

Other Assets

 

505,452


 

523,789

Total Assets

$

4,110,102


$

3,990,053




 
LIABILITIES AND EQUITY





 
Short-Term Obligations

$

70,208


$

117,866

Accounts Payable, Accrued and Other Liabilities

 

712,358


 

662,463

Total Current Liabilities

 

782,566


 

780,329

Long-Term Obligations

 

1,048,928


 

1,054,998

Deferred Liabilities and Other

 

291,945


 

303,941

Total Liabilities

 

2,123,439


 

2,139,268




 
AptarGroup, Inc. Stockholders' Equity

 

1,986,282


 

1,850,389

Noncontrolling Interests in Subsidiaries

 

381


 

396

Total Equity

 

1,986,663


 

1,850,785




 
Total Liabilities and Equity

$

4,110,102


$

3,990,053




 
AptarGroup, Inc.
Reconciliation of Adjusted EBIT and Adjusted EBITDA to Net Income (Unaudited)
($ In Thousands)







 

Three Months Ended



June 30, 2021




 

Consolidated

Pharma

Beauty + Home

Food + Beverage

Corporate & Other

Net Interest


Net Sales

$

811,032

 

 

325,343

 

 

360,246

 

 

125,443

 

 

-

 

 

-

 









 
Reported net income

$

55,274

 







Reported income taxes

 

19,020

 







Reported income before income taxes

 

74,294

 

 

81,806

 

 

12,122

 

 

9,691

 

 

(22,774

)

 

(6,551

)


Adjustments:






Restructuring initiatives

 

4,876

 

 

38

 

 

1,457

 

 

117

 

 

3,264

 



Net investment loss

 

1,611

 




 

1,611

 



Transaction costs related to acquisitions

 

2,434

 

 

2,434

 






Adjusted earnings before income taxes

 

83,215

 

 

84,278

 

 

13,579

 

 

9,808

 

 

(17,899

)

 

(6,551

)


Interest expense

 

7,175

 





 

7,175

 


Interest income

 

(624

)





 

(624

)


Adjusted earnings before net interest and taxes (Adjusted EBIT)

 

89,766

 

 

84,278

 

 

13,579

 

 

9,808

 

 

(17,899

)

 

-

 


Depreciation and amortization

 

57,790

 

 

21,701

 

 

24,331

 

 

9,818

 

 

1,940

 

 

-

 


Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)

$

147,556

 

$

105,979

 

$

37,910

 

$

19,626

 

$

(15,959

)

$

-

 









 
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)

 

18.2

%

 

32.6

%

 

10.5

%

 

15.6

%











 

Three Months Ended



June 30, 2020




 

Consolidated

Pharma

Beauty + Home

Food + Beverage

Corporate & Other

Net Interest


Net Sales

$

699,305

 

 

301,259

 

 

299,786

 

 

98,260

 

 

-

 

 

-

 









 
Reported net income

$

41,860

 







Reported income taxes

 

18,808

 







Reported income before income taxes

 

60,668

 

 

85,467

 

 

(12,755

)

 

8,519

 

 

(12,004

)

 

(8,559

)


Adjustments:






Restructuring initiatives

 

7,331

 

 

(111

)

 

7,324

 

 

75

 

 

43

 



Transaction costs related to acquisitions

 

3,207

 


 

3,207

 





Purchase accounting adjustments related to acquisitions and investments

 

3,252

 

 

293

 

 

2,959

 





Adjusted earnings before income taxes

 

74,458

 

 

85,649

 

 

735

 

 

8,594

 

 

(11,961

)

 

(8,559

)


Interest expense

 

8,734

 





 

8,734

 


Interest income

 

(175

)





 

(175

)


Adjusted earnings before net interest and taxes (Adjusted EBIT)

 

83,017

 

 

85,649

 

 

735

 

 

8,594

 

 

(11,961

)

 

-

 


Depreciation and amortization

 

56,429

 

 

18,617

 

 

25,939

 

 

9,191

 

 

2,682

 

 

-

 


Purchase accounting adjustments included in Depreciation and amortization above

 

(2,867

)

 

(167

)

 

(2,700

)





Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)

$

136,579

 

$

104,099

 

$

23,974

 

$

17,785

 

$

(9,279

)

$

-

 









 
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)

 

19.5

%

 

34.6

%

 

8.0

%

 

18.1

%











 
AptarGroup, Inc.
Reconciliation of Adjusted EBIT and Adjusted EBITDA to Net Income (Unaudited)
($ In Thousands)







 

Six Months Ended



June 30, 2021




 

Consolidated

Pharma

Beauty + Home

Food + Beverage

Corporate & Other

Net Interest


Net Sales

$

1,587,786

 

 

639,175

 

 

707,192

 

 

241,419

 

 

-

 

 

-

 









 
Reported net income

$

139,213

 







Reported income taxes

 

35,969

 







Reported income before income taxes

 

175,182

 

 

169,476

 

 

21,810

 

 

19,701

 

 

(22,220

)

 

(13,585

)


Adjustments:






Restructuring initiatives

 

8,548

 

 

73

 

 

2,553

 

 

38

 

 

5,884

 



Net investment gain

 

(15,198

)




 

(15,198

)



Transaction costs related to acquisitions

 

2,434

 

 

2,434

 






Adjusted earnings before income taxes

 

170,966

 

 

171,983

 

 

24,363

 

 

19,739

 

 

(31,534

)

 

(13,585

)


Interest expense

 

14,590

 





 

14,590

 


Interest income

 

(1,005

)





 

(1,005

)


Adjusted earnings before net interest and taxes (Adjusted EBIT)

 

184,551

 

 

171,983

 

 

24,363

 

 

19,739

 

 

(31,534

)

 

-

 


Depreciation and amortization

 

115,228

 

 

42,480

 

 

48,903

 

 

19,877

 

 

3,968

 

 

-

 


Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)

$

299,779

 

$

214,463

 

$

73,266

 

$

39,616

 

$

(27,566

)

$

-

 









 
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)

 

18.9

%

 

33.6

%

 

10.4

%

 

16.4

%











 

Six Months Ended



June 30, 2020




 

Consolidated

Pharma

Beauty + Home

Food + Beverage

Corporate & Other

Net Interest


Net Sales

$

1,420,858

 

 

598,455

 

 

624,346

 

 

198,057

 

 

-

 

 

-

 









 
Reported net income

$

97,110

 







Reported income taxes

 

41,594

 







Reported income before income taxes

 

138,704

 

 

175,321

 

 

(5,647

)

 

14,481

 

 

(28,679

)

 

(16,772

)


Adjustments:






Restructuring initiatives

 

12,170

 

 

(142

)

 

12,231

 

 

178

 

 

(97

)



Transaction costs related to acquisitions

 

4,591

 


 

4,591

 





Purchase accounting adjustments related to acquisitions and investments

 

4,642

 

 

1,421

 

 

3,221

 





Adjusted earnings before income taxes

 

160,107

 

 

176,600

 

 

14,396

 

 

14,659

 

 

(28,776

)

 

(16,772

)


Interest expense

 

17,122

 





 

17,122

 


Interest income

 

(350

)





 

(350

)


Adjusted earnings before net interest and taxes (Adjusted EBIT)

 

176,879

 

 

176,600

 

 

14,396

 

 

14,659

 

 

(28,776

)

 

-

 


Depreciation and amortization

 

107,235

 

 

36,508

 

 

46,525

 

 

18,533

 

 

5,669

 

 

-

 


Purchase accounting adjustments included in Depreciation and amortization above

 

(3,367

)

 

(667

)

 

(2,700

)





Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)

$

280,747

 

$

212,441

 

$

58,221

 

$

33,192

 

$

(23,107

)

$

-

 









 
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)

 

19.8

%

 

35.5

%

 

9.3

%

 

16.8

%











 
AptarGroup, Inc.
Reconciliation of Adjusted Earnings Per Diluted Share (Unaudited)
(In Thousands, Except Per Share Data)





 

Three Months Ended

Six Months Ended



June 30,

June 30,



 

2021

 

2020

 

 

2021

 

 

2020

 







 
Income before Income Taxes

$

74,294

$

60,668

 

$

175,182

 

$

138,704

 







 
Adjustments:




Restructuring initiatives

 

4,876

 

7,331

 

 

8,548

 

 

12,170

 


Net investment loss (gain)

 

1,611

 

-

 

 

(15,198

)

 

-

 


Transaction costs related to acquisitions

 

2,434

 

3,207

 

 

2,434

 

 

4,591

 


Purchase accounting adjustments related to acquisitions and investments

 

-

 

3,252

 

 

-

 

 

4,642

 


Foreign currency effects (1)

 

4,640

 


 

10,296

 


Adjusted Earnings before Income Taxes

$

83,215

$

79,098

 

$

170,966

 

$

170,403

 







 





 
Provision for Income Taxes

$

19,020

$

18,808

 

$

35,969

 

$

41,594

 







 
Adjustments:




Restructuring initiatives

 

1,144

 

1,503

 

 

1,985

 

 

2,702

 


Net investment loss (gain)

 

370

 

-

 

 

(3,496

)

 

-

 


Transaction costs related to acquisitions

 

442

 

481

 

 

442

 

 

689

 


Purchase accounting adjustments related to acquisitions and investments

 

-

 

727

 

 

-

 

 

1,026

 


Foreign currency effects (1)

 

1,440

 


 

3,089

 


Adjusted Provision for Income Taxes

$

20,976

$

22,959

 

$

34,900

 

$

49,100

 







 





 
Net Income Attributable to Noncontrolling Interests

$

2

$

(21

)

$

15

 

$

(18

)







 
Net Income Attributable to AptarGroup, Inc.

$

55,276

$

41,839

 

$

139,228

 

$

97,092

 







 
Adjustments:




Restructuring initiatives

 

3,732

 

5,828

 

 

6,563

 

 

9,468

 


Net investment loss (gain)

 

1,241

 

-

 

 

(11,702

)

 

-

 


Transaction costs related to acquisitions

 

1,992

 

2,726

 

 

1,992

 

 

3,902

 


Purchase accounting adjustments related to acquisitions and investments

 

-

 

2,525

 

 

-

 

 

3,616

 


Foreign currency effects (1)

 

3,200

 


 

7,207

 


Adjusted Net Income Attributable to AptarGroup, Inc.

$

62,241

$

56,118

 

$

136,081

 

$

121,285

 







 
Average Number of Diluted Shares Outstanding

 

68,086

 

66,384

 

 

67,869

 

 

66,246

 







 
Net Income Attributable to AptarGroup, Inc. Per Diluted Share

$

0.81

$

0.63

 

$

2.05

 

$

1.47

 







 
Adjustments:




Restructuring initiatives

 

0.05

 

0.09

 

 

0.10

 

 

0.14

 


Net investment loss (gain)

 

0.02

 

-

 

 

(0.17

)

 

-

 


Transaction costs related to acquisitions

 

0.03

 

0.04

 

 

0.03

 

 

0.06

 


Purchase accounting adjustments related to acquisitions and investments

 

-

 

0.04

 

 

-

 

 

0.05

 


Foreign currency effects (1)

 

0.05

 


 

0.11

 


Adjusted Net Income Attributable to AptarGroup, Inc. Per Diluted Share

$

0.91

$

0.85

 

$

2.01

 

$

1.83

 







 
(1) Foreign currency effects are approximations of the adjustment necessary to state the prior year earnings and earnings per share using current period foreign currency exchange rates.

 
AptarGroup, Inc.
Reconciliation of Free Cash Flow to Net Cash Provided by Operations (Unaudited)
(In Thousands)





 

Three Months Ended

Six Months Ended



June 30,

June 30,



 

2021

 

2020

 

2021

 

2020







 
Net Cash Provided by Operations

$

103,396

$

142,653

$

175,581

$

227,686


Less:




Capital Expenditures

$

73,155

$

61,361

$

137,039

$

122,986


Free Cash Flow

$

30,241

$

81,292

$

38,542

$

104,700







 
AptarGroup, Inc.
Reconciliation of Adjusted Earnings Per Diluted Share (Unaudited)
(In Thousands, Except Per Share Data)



 

Three Months Ending



September 30,



Expected 2021

 

2020

 





 
Income before Income Taxes

$

89,139

 





 
Adjustments:


Restructuring initiatives

 

3,415

 


Net investment loss (gain)

 

-

 


Transaction costs related to acquisitions

 

221

 


Purchase accounting adjustments related to acquisitions and investments

 

-

 


Foreign currency effects (1)

 

1,105

 


Adjusted Earnings before Income Taxes

$

93,880

 





 



 
Provision for Income Taxes

$

25,404

 





 
Adjustments:


Restructuring initiatives

 

598

 


Net investment loss (gain)

 

-

 


Transaction costs related to acquisitions

 

25

 


Purchase accounting adjustments related to acquisitions and investments

 

-

 


Foreign currency effects (1)

 

315

 


Adjusted Provision for Income Taxes

$

26,342

 





 



 
Net Income Attributable to Noncontrolling Interests

$

(19

)





 
Net Income Attributable to AptarGroup, Inc.

$

63,716

 





 
Adjustments:


Restructuring initiatives

 

2,817

 


Net investment loss (gain)

 

-

 


Transaction costs related to acquisitions

 

196

 


Purchase accounting adjustments related to acquisitions and investments

 

-

 


Foreign currency effects (1)

 

790

 


Adjusted Net Income Attributable to AptarGroup, Inc.

$

67,519

 





 
Average Number of Diluted Shares Outstanding

 

66,922

 





 
Net Income Attributable to AptarGroup, Inc. Per Diluted Share (2)

$

0.95

 





 
Adjustments:


Restructuring initiatives

 

0.05

 


Net investment loss (gain)

 

-

 


Transaction costs related to acquisitions

 

-

 


Purchase accounting adjustments related to acquisitions and investments

 

-

 


Foreign currency effects (1)

 

0.01

 


Adjusted Net Income Attributable to AptarGroup, Inc. Per Diluted Share (2) $0.90 - $0.98

$

1.01

 





 
(1) Foreign currency effects are approximations of the adjustment necessary to state the prior year earnings per share using foreign currency exchange rates.
(2) AptarGroup’s expected earnings per share range for the third quarter of 2021, excluding any restructuring expenses, acquisition costs and changes in fair value of equity investments, is based on an effective tax rate range of 28% to 30%. This tax rate range compares to our third quarter of 2020 effective tax rate of 28% on reported and adjusted earnings per share.

 

Contacts

Investor Relations Contact:

Matt DellaMaria
matt.dellamaria@aptar.com
815-479-5530

Media Contact:

Katie Reardon
katie.reardon@aptar.com
815-479-5671

EX-101.SCH 3 atr-20210729.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 atr-20210729_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 5 atr-20210729_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 a52468729_htm.xml IDEA: XBRL DOCUMENT 0000896622 2021-07-29 2021-07-29 false 0000896622 8-K 2021-07-29 AptarGroup, Inc. DE 001-11846 36-3853103 265 Exchange Drive Suite 100 Crystal Lake IL 60014 815 477-0424 false false false false Common Stock, $.01 par value ATR NYSE false XML 7 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information
Jul. 29, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 29, 2021
Entity Registrant Name AptarGroup, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-11846
Entity Tax Identification Number 36-3853103
Entity Address, Address Line One 265 Exchange Drive
Entity Address, Address Line Two Suite 100
Entity Address, City or Town Crystal Lake
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60014
City Area Code 815
Local Phone Number 477-0424
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000896622
Title of 12(b) Security Common Stock, $.01 par value
Trading Symbol ATR
Security Exchange Name NYSE
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://aptar.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports a52468729.htm a52468729ex99_1.htm atr-20210729.xsd atr-20210729_lab.xml atr-20210729_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "a52468729.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "a52468729.htm" ] }, "labelLink": { "local": [ "atr-20210729_lab.xml" ] }, "presentationLink": { "local": [ "atr-20210729_pre.xml" ] }, "schema": { "local": [ "atr-20210729.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "atr", "nsuri": "http://aptar.com/20210729", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "a52468729.htm", "contextRef": "c20210729to20210729", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://aptar.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "a52468729.htm", "contextRef": "c20210729to20210729", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0001157523-21-000953-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001157523-21-000953-xbrl.zip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

F&W*][P-&&B>![_?E,YFIO]"O,>IM?,L/CMR&%IBU^:;1F M%7*_SG@)M2AUVE0Q+!L\,NN";V#2&JII!-V'4^*[W$8KE"VQXV1\'<1:I"8$ M'K<>J7@N5M.#9OJU';FSL%2J&W%!_K_YSB*_R?_/_OP?4$L! A0#% @ M79#]4K8/VY$9$@ :V4 T ( ! &$U,C0V.#&UL4$L! A0#% @ 79#]4H>5/7O@!0 Z#X !0 M ( !87H &%T&UL4$L%!@ % - 4 /@$ '. $! end